Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251 = Streptomyces sp. A251이 생산하는 enoyl-ACP reductase 저해 항세균 methyl-branched fatty acid 물질
Cited 6 time in
- Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251 = Streptomyces sp. A251이 생산하는 enoyl-ACP reductase 저해 항세균 methyl-branched fatty acid 물질
- C J Zheng; Mi Jin Sohn; Seung-Wook Chi; Won Gon Kim
- Bibliographic Citation
- Journal of Microbiology and Biotechnology, vol. 20, no. 5, pp. 875-880
- Publication Year
- Bacterial enoyl-ACP reductase (FabI) has been demonstrated to be a novel antibacterial target. In the course of our screening for FabI inhibitors, we isolated two methyl-branched fatty acids from Streptomyces sp. A251. They were identified as 14-methyl-9(Z)-pentadecenoic acid and 15-methyl-9(Z)-hexadecenoic acid by MS and NMR spectral data. These compounds inhibited Staphylococcus aureus FabI with IC50 values of 16.0 and 16.3 uM, respectively, but did not affect FabK, an enoyl-ACP reductase of Streptococcus pneumonia, at 100 uM. Consistent with their selective inhibition for FabI, they blocked intracellular fatty acid synthesis as well as the growth of S. aureus, but did not inhibit the growth of S. pneumonia. Additionally, these compounds showed reduced antibacterial activity against /abl-overexpressing S. aureus, compared with the wild-type strain. These results demonstrate that the methyl-branched fatty acids show antibacterial activity by inhibiting FabI in vivo.
- Antibacterial activityEnoyl-ACP reductaseMethyl-branched fatty acidStaphylococcus aureus
- Korea Soc-Assoc-Inst
- Appears in Collections:
- Division of Biomedical Research > 1. Journal Articles
Division of Research on National Challenges > Infectious Disease Research Center > 1. Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.